Irregular cytokine pattern of CD4+ T lymphocytes in response to Staphylococcus aureus in patients with Wegener's granulomatosis

Scandinavian Journal of Immunology

Volumn 49, Issue 6, 1999, Pages 585-594

  Mayet, W J ^a,b   Marker Hermann E ^a   Schlaak, J ^a   Meyer Zum Buschenfelde K H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; T LYMPHOCYTE SUBPOPULATION; WEGENER GRANULOMATOSIS;

ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WEGENER GRANULOMATOSIS;

EID: 0033011157     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00544.x     Document Type: Article

References (45)

1. 1 Cohen Tervaert JW, van der Woude FJ, Fauci AS et al. Association between Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989;149:2461-5.
2. 2 Kallenberg CGM, Cohen Tervaert JW, van der Woude FJ, von Goldschmeding R, dem Borne AEGK, Weening JJ. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today 1991;12:61-4.
3. 3 Schmitt WH, Heesen C, Csernok E. Elevated serum levels of soluble interleukin-2-receptor (sIL-2R) in Wegener's granulomatosis (WG): association with disease activity. Arthritis Rheum 1992;35:108-10.
4. 4 Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CGM. Serum markers of T-cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 1993;91:415-20.
5. 5 Gephardt GN, Ahmad M, Tubbs RR. Pulmonary vasculitis (Wegener's granulomatosis) immunohistochemical study of T and B cell markers. Am J Med 1983;74:700-4.
6. 6 Churg J. Nomenclature of vasculitic syndromes: a histological perspective. Am J Kidney Dis 1991;18:148-53.
7. 7 Hooke DH, Gee DC, Atkins RC. Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987;31:961-72.
8. 8 Mathieson PW, Lockwood CM, Oliviera DGB. T and B cell responses to cytoplasmic antigens in systemic vasculitis. Clin Immunol Immunopathol 1992;63:135-41.
9. 9 van der Woude FJ, van Es LA, Daha MR. The role of the cANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms. Neth J Med 1990;36:169-71.
10. 10 Ballieux BEPB, van der Burg SH, Hagen EC, van der Woude FJ, Melief CJM, Daha MR. Cell mediated autoimmunity in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1995;100:186-93.
11. 11 Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CGM. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1994;98:448-53.
12. 12 Rasmussen N, Petersen J. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides. J Autoimmun 1993;6:227-36.
13. 13 King WJ, Brooks CJ, Holder R, Hughes P, Adu D, Savage COS. T-lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol 1998;112:539-46.
14. 14 Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of antineutrophil cytoplasmic autoantibodies-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990;113:656-63.
15. 15 Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegeners granulomatosis. Ann Intern Med 1994;120:12-7.
16. 16 Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
17. 17 Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
18. 18 Cohen Tervaert JW, Goldschmeding R, Elema JD et al. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37:799-806.
19. 19 Mayet WJ, Bachmann M, Pfeifer K, Schröder HC, Müller WEG, Meyer zum Büschenfelde KH. A monoclonal Ro-antibody and the serum of a Ro-positive patient with subacute cutaneous lupus erythematosus (SCLE) react with basal layers of human epidermis. Eur J Clin Invest 1988;18:465-71.
20. 20 Mayet WJ, Hermann E, Finsterwalder J, Rieder H, Poralla T, Meyer zum Büschenfelde KH. Antibodies to cathepsin G in Crohn's disease. Eur J Clin Invest 1992;22:427-33.
21. 21 Kao RC, Wehner NG, Skubitz KM, Gray H, Hoidal J. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 1988;82:1963-73.
22. 22 Mayet WJ, Hess G, Gerken G et al. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989;10:24-8.
23. 23 Stummann L, Wiik A. A simple high yield procedure for purification of human proteinase 3, the main molecular target of ANCA. J Immunol Methods 1997;206:35-42.
24. 24 Gaskin G, Kendal H, Coulthart A, Turner N, Pusey CD. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis. J Immunol Methods 1995;180:25-9.
25. 25 Märker-Hermann E. T cell responses in rheumatology. In: Lefkovitz I, ed. Immunological Methods Manual Chapter 24.4. Academic Press Ltd London. 1996: 1637-49.
26. 26 Schlaak JF, Pfers I, Meyer zum Büschenfelde KH, Märker-Hermann E. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathics. Clin Exp Rheumatol 1996;14:155-62.
27. 27 Mayet WJ, Schwarting A, Meyer zum Büschenfelde KH. Cytotoxic effects of antibodies to proteinase 3 (c-ANCA) on human endothelial cells. Clin Hxp Immunol 1994;97:458-65.
28. 28 Pinching AJ, Rees AJ, Russell BA, Lockwood CM, Mitchison RS, Peters DK. Relapses in Wegener's granulomatosis: the role of infection. Br Med J 1980;281:836-40.
29. 29 de Remee RA, McDonald TJ, Welland LH. Wegener's granulomatosis: observations on treatment with antimicrobila agents. Mayo Clin Proc 1985;60:27-31.
30. 30 Israel HL. Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis. Arch Intern Med 1988;148:2293-5.
31. 31 Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Immunohistopathology of renal biopsies in Wegener's granulomalosis (WG): clues for its pathogenesis? Am J Kidney Dis 1990;1:558.
32. 32 Rasmussen N, Petersen J, Ralfkiaer E, Avnstrom E, Wiik A. Spontaneous and induced immunoglobulin synthesis and antineutrophil cytoplasm antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions. Rheumatol Int 1988;8:153-8.
33. 33 Noronha IL, Andrassy K, Ritz E, Waldherr R. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 receptors (IL-2R) in systemic vasculitis. J Am Soc Nephrol 1991;2:602.
34. 34 Jayne DRW, Weetman AP, Lockwood CM. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991;84:476-81.
35. 35 Brouwer E, Cohen Tervaert JW, Horst G et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991;83:379-86.
36. 36 Alberse RC, van der Gaag R, van Leeuwen J. Serologic aspects of IgG4 antibodies. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983;130:722-6.
37. 37 Griffith ME, Coulthart A, Pusey CD. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin Exp Immunol 1996;103:253-8
38. 38 Petersen J, Rasmussen N, Szirpt W, Hermann E, Mayet W. T-lymphocyte proliferation to neutrophil cytoplasmic antigen (S) in Wegener's Granulomatosis (WG). Am J Kidney Dis 1991;18:205.
39. 39 Agostini C, Basso U, Semenzato G. Cells and molecules involved in the development of sarcoid granuloma. J Clin Immunol 1998;18:184-92.
40. 40 Schlaak JF, Nieder P, Meyer zum Bueschenfelde KH, Fleischer B. Human T helper cells reactive with somatic bacterial antigens belong to the Th1 subset. Med Microbiol Immunol Berl 1994;183:169-75.
41. 41 Wang G, Hansen H, Tatsis E, Csernok E, Lemke H, Gross WL. High plasma levels of the soluble form of CD 30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997;102:517-23.
42. 42 Mosmann T, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-46.
43. 43 Spiegelberg HL. Biological role of different antibody classes. Int Arch Allergy Appl Immunol 1990;90:22.
44. 44 Mayet WJ, Helmreich-Becker I, Meyer zum Büschenfelde KH. The pathophysiology of anti-neutrophil cytoplasmic antibodies (ANCA) and their clinical relevance. Crit Rev Oncol/Hematol 1996;23:151-65.
45. 45 St Louis JD, Lederer JA, Liehtman AH. Costimulatory deficient antigen presentation by an endothelial cell line induces non proliferative T-cell activation response without anergy. J Exp Med 1993;178:1597-605.